HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Biltmore Wealth Management LLC

Biltmore Wealth Management LLC increased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 5.4% in the 4th quarter, HoldingsChannel reports. The fund owned 2,528 shares of the company’s stock after purchasing an additional 129 shares during the quarter. Biltmore Wealth Management LLC’s holdings in HCA Healthcare were worth $759,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of HCA. Tuttle Capital Management LLC lifted its holdings in shares of HCA Healthcare by 34.7% in the 4th quarter. Tuttle Capital Management LLC now owns 1,055 shares of the company’s stock worth $317,000 after acquiring an additional 272 shares during the last quarter. Marcum Wealth LLC boosted its position in shares of HCA Healthcare by 14.6% during the fourth quarter. Marcum Wealth LLC now owns 706 shares of the company’s stock worth $212,000 after buying an additional 90 shares during the period. Miracle Mile Advisors LLC acquired a new position in HCA Healthcare during the 4th quarter worth about $385,000. Eastern Bank acquired a new position in HCA Healthcare in the 4th quarter valued at about $62,000. Finally, Trust Co. of Toledo NA OH lifted its position in shares of HCA Healthcare by 2.0% during the fourth quarter. Trust Co. of Toledo NA OH now owns 3,287 shares of the company’s stock worth $987,000 after purchasing an additional 63 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Up 1.7 %

Shares of NYSE HCA opened at $307.97 on Tuesday. HCA Healthcare, Inc. has a 52-week low of $276.50 and a 52-week high of $417.14. The stock has a market capitalization of $78.01 billion, a PE ratio of 13.83, a P/E/G ratio of 1.21 and a beta of 1.64. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a fifty day moving average of $320.56 and a 200-day moving average of $353.55.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were issued a $0.66 dividend. The ex-dividend date was Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.86%. HCA Healthcare’s payout ratio is 11.85%.

Insider Transactions at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

HCA has been the topic of a number of research reports. KeyCorp reduced their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. JPMorgan Chase & Co. reissued a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price target for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Finally, StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $385.27.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.